{"id":13828,"date":"2021-01-04T12:40:09","date_gmt":"2021-01-04T11:40:09","guid":{"rendered":"https:\/\/www.resist-cluster.de\/?page_id=13828"},"modified":"2022-02-02T13:02:04","modified_gmt":"2022-02-02T12:02:04","slug":"prof-dr-gisa-gerold","status":"publish","type":"page","link":"https:\/\/www.resist-cluster.de\/en\/about-us\/research-team-2\/prof-dr-gisa-gerold\/","title":{"rendered":"Prof. Dr. Gisa Gerold"},"content":{"rendered":"

<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/a><\/span><\/div>

Prof. Dr. Gisa Gerold<\/p>\n<\/div>

<\/div><\/div><\/div>

\n\n\n
<\/i><\/td>\nMy Research Interest in RESIST<\/td>\n<\/tr>\n<\/tbody>\n<\/table><\/h1><\/div>

Within RESIST we focus on elucidating inter-individual differences in the susceptibility to chronic arthritis causing viruses. Particularly, we focus on the mosquito-transmitted Chikungunya virus, which is emerging in Europe. To date, we lack knowledge on whether certain individuals are at higher risk of contracting the disease and progressing to chronic arthritis. Recently, we identified a novel human factor, which is critical for Chikungunya infection. Using experimental models of virus infection in conjunction with ectopic expression of genetic variants of the human factor, we aim to understand how our genetic make up shapes the interaction with the virus. The knowledge gained will enable our colleagues and us in RESIST to define potential risk groups in the human population.<\/p>\n<\/div>

<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/path><\/svg><\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div><\/div><\/div>
<\/div>
<\/div>
<\/div>
<\/div>
<\/div><\/div><\/div>
<\/div><\/div><\/div>

Prof. Dr. Gerold about her scientific work<\/h1><\/div>